Original Research
Accepted on 03 Nov 2025
Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a post hoc analysis of a phase II/III trial
in Inflammation Pharmacology
Original Research
Accepted on 03 Nov 2025
in Inflammation Pharmacology
Perspective
Accepted on 03 Nov 2025
in Cytokines and Soluble Mediators in Immunity
Original Research
Accepted on 03 Nov 2025
in Climate-Smart Food Systems
Review
Accepted on 03 Nov 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 03 Nov 2025
in Computational Physiology and Medicine
Original Research
Accepted on 03 Nov 2025
in Sport Psychology
Original Research
Accepted on 03 Nov 2025
in Personality and Social Psychology
Original Research
Accepted on 03 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 03 Nov 2025
in Viral Immunology
Original Research
Accepted on 03 Nov 2025
in Computational Physiology and Medicine
Case Report
Accepted on 03 Nov 2025
in Thoracic Oncology
Original Research
Accepted on 03 Nov 2025
in Veterinary Infectious Diseases
Original Research
Accepted on 03 Nov 2025
in Pharmacoepidemiology
Review
Accepted on 03 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 03 Nov 2025
in Ethnopharmacology
Original Research
Accepted on 03 Nov 2025
in Cancer Immunity and Immunotherapy